Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Bioengineered Protein Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Bioengineered Protein Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Recombinant protein drugs
      • 1.3.3 Peptide hormones
      • 1.3.4 Vaccines
      • 1.3.5 Therapeutic enzymes
      • 1.3.6 Monoclonal antibodies
      • 1.3.7 Cytokines
      • 1.3.8 Replacement proteins
      • 1.3.9 Peptide antibiotics
      • 1.3.10 Blood products
    • 1.4 Market Segment by Application
      • 1.4.1 Global Bioengineered Protein Drugs Market Share by Application (2019-2025)
      • 1.4.2 Fractionation
      • 1.4.3 Bioreactors and microbial cell fermentation
      • 1.4.4 Genetic engineering
      • 1.4.5 Genetically modified organisms
      • 1.4.6 Pharming
      • 1.4.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
      • 1.4.8 Cell culture
      • 1.4.9 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Bioengineered Protein Drugs Market Size
      • 2.1.1 Global Bioengineered Protein Drugs Revenue 2014-2025
      • 2.1.2 Global Bioengineered Protein Drugs Sales 2014-2025
    • 2.2 Bioengineered Protein Drugs Growth Rate by Regions
      • 2.2.1 Global Bioengineered Protein Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Bioengineered Protein Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Bioengineered Protein Drugs Sales by Manufacturers
      • 3.1.1 Bioengineered Protein Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Bioengineered Protein Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Bioengineered Protein Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bioengineered Protein Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Bioengineered Protein Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Bioengineered Protein Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Bioengineered Protein Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Bioengineered Protein Drugs Market
    • 3.6 Key Manufacturers Bioengineered Protein Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Recombinant protein drugs Sales and Revenue (2014-2019)
      • 4.1.2 Peptide hormones Sales and Revenue (2014-2019)
      • 4.1.3 Vaccines Sales and Revenue (2014-2019)
      • 4.1.4 Therapeutic enzymes Sales and Revenue (2014-2019)
      • 4.1.5 Monoclonal antibodies Sales and Revenue (2014-2019)
      • 4.1.6 Cytokines Sales and Revenue (2014-2019)
      • 4.1.7 Replacement proteins Sales and Revenue (2014-2019)
      • 4.1.8 Peptide antibiotics Sales and Revenue (2014-2019)
      • 4.1.9 Blood products Sales and Revenue (2014-2019)
    • 4.2 Global Bioengineered Protein Drugs Sales Market Share by Type
    • 4.3 Global Bioengineered Protein Drugs Revenue Market Share by Type
    • 4.4 Bioengineered Protein Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Bioengineered Protein Drugs Sales by Application

    6 United States

    • 6.1 United States Bioengineered Protein Drugs Breakdown Data by Company
    • 6.2 United States Bioengineered Protein Drugs Breakdown Data by Type
    • 6.3 United States Bioengineered Protein Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Bioengineered Protein Drugs Breakdown Data by Company
    • 7.2 European Union Bioengineered Protein Drugs Breakdown Data by Type
    • 7.3 European Union Bioengineered Protein Drugs Breakdown Data by Application

    8 China

    • 8.1 China Bioengineered Protein Drugs Breakdown Data by Company
    • 8.2 China Bioengineered Protein Drugs Breakdown Data by Type
    • 8.3 China Bioengineered Protein Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Bioengineered Protein Drugs Breakdown Data by Company
    • 9.2 Rest of World Bioengineered Protein Drugs Breakdown Data by Type
    • 9.3 Rest of World Bioengineered Protein Drugs Breakdown Data by Application
    • 9.4 Rest of World Bioengineered Protein Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Bioengineered Protein Drugs Sales by Countries
      • 9.4.2 Rest of World Bioengineered Protein Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abbot
      • 10.1.1 Abbot Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.1.4 Bioengineered Protein Drugs Product Introduction
      • 10.1.5 Abbot Recent Development
    • 10.2 Amgen
      • 10.2.1 Amgen Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.2.4 Bioengineered Protein Drugs Product Introduction
      • 10.2.5 Amgen Recent Development
    • 10.3 Baxter
      • 10.3.1 Baxter Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.3.4 Bioengineered Protein Drugs Product Introduction
      • 10.3.5 Baxter Recent Development
    • 10.4 Bayer
      • 10.4.1 Bayer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.4.4 Bioengineered Protein Drugs Product Introduction
      • 10.4.5 Bayer Recent Development
    • 10.5 Eli Lilly
      • 10.5.1 Eli Lilly Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.5.4 Bioengineered Protein Drugs Product Introduction
      • 10.5.5 Eli Lilly Recent Development
    • 10.6 GlaxoSmithKline
      • 10.6.1 GlaxoSmithKline Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.6.4 Bioengineered Protein Drugs Product Introduction
      • 10.6.5 GlaxoSmithKline Recent Development
    • 10.7 Fresenius Kabi
      • 10.7.1 Fresenius Kabi Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.7.4 Bioengineered Protein Drugs Product Introduction
      • 10.7.5 Fresenius Kabi Recent Development
    • 10.8 Hoffman-la-Roche
      • 10.8.1 Hoffman-la-Roche Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.8.4 Bioengineered Protein Drugs Product Introduction
      • 10.8.5 Hoffman-la-Roche Recent Development
    • 10.9 Johnson & Johnson
      • 10.9.1 Johnson & Johnson Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.9.4 Bioengineered Protein Drugs Product Introduction
      • 10.9.5 Johnson & Johnson Recent Development
    • 10.10 Merck
      • 10.10.1 Merck Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Bioengineered Protein Drugs
      • 10.10.4 Bioengineered Protein Drugs Product Introduction
      • 10.10.5 Merck Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Bioengineered Protein Drugs Sales Channels
      • 11.2.2 Bioengineered Protein Drugs Distributors
    • 11.3 Bioengineered Protein Drugs Customers

    12 Market Forecast

    • 12.1 Global Bioengineered Protein Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Bioengineered Protein Drugs Sales Forecast by Type
    • 12.3 Global Bioengineered Protein Drugs Sales Forecast by Application
    • 12.4 Bioengineered Protein Drugs Forecast by Regions
      • 12.4.1 Global Bioengineered Protein Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Bioengineered Protein Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries.
      In 2019, the market size of Bioengineered Protein Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bioengineered Protein Drugs.

      This report studies the global market size of Bioengineered Protein Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Bioengineered Protein Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbot
      Amgen
      Baxter
      Bayer
      Eli Lilly
      GlaxoSmithKline
      Fresenius Kabi
      Hoffman-la-Roche
      Johnson & Johnson
      Merck

      Market Segment by Product Type
      Recombinant protein drugs
      Peptide hormones
      Vaccines
      Therapeutic enzymes
      Monoclonal antibodies
      Cytokines
      Replacement proteins
      Peptide antibiotics
      Blood products

      Market Segment by Application
      Fractionation
      Bioreactors and microbial cell fermentation
      Genetic engineering
      Genetically modified organisms
      Pharming
      Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
      Cell culture
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Bioengineered Protein Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Bioengineered Protein Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Bioengineered Protein Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now